Stevens J Drug Patent Portfolio

Stevens J owns 1 orange book drug protected by 1 US patent Given below is the list of Stevens J's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9050307 Method for the preparation of a levothyroxine solution 06 Aug, 2031
Active


Given below is the list of recent legal activities going on the following drug patents of Stevens J.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 07 Dec, 2022 US9050307
Payment of Maintenance Fee, 4th Yr, Small Entity 26 Nov, 2018 US9050307
Post Issue Communication - Certificate of Correction 13 Jul, 2016 US9050307
Post Issue Communication - Certificate of Correction 18 Mar, 2016 US9050307
Application ready for PDX access by participating foreign offices 31 Aug, 2015 US9050307
Recordation of Patent Grant Mailed 09 Jun, 2015 US9050307
Patent Issue Date Used in PTA Calculation 09 Jun, 2015 US9050307
Email Notification 21 May, 2015 US9050307
Issue Notification Mailed 20 May, 2015 US9050307
Dispatch to FDC 08 May, 2015 US9050307
Application Is Considered Ready for Issue 06 May, 2015 US9050307
Issue Fee Payment Verified 05 May, 2015 US9050307
Issue Fee Payment Received 05 May, 2015 US9050307
Electronic Review 08 Apr, 2015 US9050307
Email Notification 08 Apr, 2015 US9050307


Stevens J Drug Patents' Oppositions Filed in EPO

Stevens J drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jul 11, 2016, by Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A.. This opposition was filed on patent number EP11711688A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP11711688A Jul, 2016 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Granted and Under Opposition


Stevens J's Family Patents

Stevens J drugs have patent protection in a total of 12 countries. It's US patent count contributes only to 8.3% of its total global patent coverage. 2 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Stevens J Drug List

Given below is the complete list of Stevens J's drugs and the patents protecting them.


1. Thyquidity

Thyquidity is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US9050307 Method for the preparation of a levothyroxine solution 06 Aug, 2031
(6 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Thyquidity's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List